Chronic pulmonary aspergillosis in tea population of Assam
- PMID: 39778079
- PMCID: PMC11709265
- DOI: 10.1371/journal.pntd.0012756
Chronic pulmonary aspergillosis in tea population of Assam
Abstract
Background: Chronic pulmonary aspergillosis (CPA) is a disease commonly caused by Aspergillus fumigatus and other Aspergillus species characterized by cavitary lung lesions. Tea garden population is an agrarian population of Assam, mostly associated with tea plantations. Assam is a major tea-producing state with 803 tea gardens producing approximately 50% of the total tea in India, of which 177 are present in the Dibrugarh district alone. Tuberculosis is common in tea garden workers. This community-based cross-sectional study in the tea garden community of Dibrugarh was done to find the prevalence of Aspergillus IgG antibodies and CPA cases in individuals with chronic respiratory symptoms.
Methodology and principal findings: Patients visiting 3 tea garden hospitals and 2 referral hospitals with chronic cough and/or haemoptysis, weight loss/fatigue, and other respiratory symptoms for a duration of 3 months or more were included in this one-year study. Serum samples were tested by Immunocap Phadia 200 for Aspergillus fumigatus-specific IgG antibodies. CPA cases were diagnosed based on clinical, radiological, and serological criteria. Out of 128 samples, seropositivity was seen in 41 (32.0%) patients (cutoff value: 27 mgA/l). Male preponderance (1.6:1) with a mean age of 41.9 (±15.69) was observed. Haemoptysis and fatigue were significant symptoms seen (p-values: 0.0086 and 0.0098, respectively). Aspergillus fumigatus-specific IgG antibody was found to be significantly high in 29 out of 76 patients (38.1%) with a history of tuberculosis. Amongst them, seropositivity with active TB was 5 out of 27 patients (18.5%), and seropositivity with post-TB was 24 out of 49 patients (48.9%). Chronic cavitary pulmonary aspergillosis was the predominant type (38.1%). Proven CPA (clinically, radiologically, and serologically positive) were 22 (17.1%, 95% CI 10.7%-26.0%), and possible CPA (clinically and serologically positive but without radiological data) were 19 (14.8%, 95% CI 8.9%-23.1%).
Conclusion: A high prevalence of CPA (60 per 100 000) was detected. High Aspergillus seropositivity of 48.9% was seen in the post-TB population. Aspergillus-specific IgG antibody testing is the only confirmatory method for diagnosing CPA, which is available in limited centres in India. Aspergillus seropositivity should be detected in post-TB patients presenting with chronic respiratory symptoms.
Copyright: © 2025 Selvasekhar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures






Similar articles
-
Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis.Mycoses. 2018 Oct;61(10):770-776. doi: 10.1111/myc.12815. Epub 2018 Jul 12. Mycoses. 2018. PMID: 29920796
-
Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study.Clin Microbiol Infect. 2020 Aug;26(8):1091.e1-1091.e7. doi: 10.1016/j.cmi.2019.12.009. Epub 2020 Jan 1. Clin Microbiol Infect. 2020. PMID: 31901491
-
Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1759-65. doi: 10.1007/s10096-015-2409-7. Epub 2015 May 24. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26003310
-
LDBio Aspergillus immunochromatographic test lateral flow assay for IgG/IgM antibody detection in chronic pulmonary aspergillosis: Single-centre evaluation and meta-analysis.Indian J Med Microbiol. 2022 Apr-Jun;40(2):204-210. doi: 10.1016/j.ijmmb.2022.03.002. Epub 2022 Apr 1. Indian J Med Microbiol. 2022. PMID: 35370006
-
Challenges in the diagnosis and treatment of chronic pulmonary aspergillosis in Japan.Respir Investig. 2025 Jul;63(4):488-494. doi: 10.1016/j.resinv.2025.04.005. Epub 2025 Apr 17. Respir Investig. 2025. PMID: 40250141 Review.
References
-
- Sehgal IS, Prabhakar N, Rana S, Raju R, Dhooria S, Prasad KT, et al.. Incidence and prevalence of chronic pulmonary aspergillosis in patients with post-tuberculosis lung abnormality: results from a community survey in North India. Mycoses. 2024. Mar;67(3):e13711. doi: 10.1111/myc.13711 - DOI - PubMed
-
- Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, et al.. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018. Aug [cited 2024 Jul 7];24(8). Available from: https://wwwnc.cdc.gov/eid/article/24/8/17-1312_article - PMC - PubMed
-
- Bongomin F, Olum R, Kibone W, Namusobya M, van Rhijn N, Denning DW. Prevalence of chronic pulmonary aspergillosis along the continuum of pulmonary tuberculosis care: a protocol for a living systematic review and meta-analysis. PLoS ONE. 2023. Dec 15;18(12):e0294634. doi: 10.1371/journal.pone.0294634 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources